Martin Babler

ALMS

Martin Babler serves as President, CEO and Chairman at Alumis Inc. Common Stock (ALMS). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

1 trades

$100.7K

Total Sells

0 trades

$0.00

Net Position

Net Buyer

$100.7K

Companies Traded

ALMS

Active Period

Apr 2025

1 total trades

Most Recent

Buy ALMS

Apr 1, 2025 · $100.7K

Martin Babler's Insider Trading at Alumis Inc. Common Stock (ALMS)

Buys

1 · $100.7K

Sells

0 · $0.00

Total Shares Bought

15,650

Total Shares Sold

ALMS Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Apr 1, 2025	Buy	15,650	$6.44	$100.7K	0

Related Insiders

AKKARAJU SRINIVAS

Director

ALMSBuy · Sep 9, 2026

Mark Christopher Bradley

officer: Chief Development Officer

ALMSSell · Aug 5, 2026

Jorn Drappa

officer: Chief Medical Officer

ALMSSell · Aug 5, 2026

David M Goldstein

officer: Chief Scientific Officer

ALMSSell · Aug 5, 2026

Roy C. Hardiman

officer: Chief Business & Strategy Ofcr

ALMSSell · Aug 5, 2026

Sanam Pangali

officer: Chief Legal Officer

ALMSSell · Aug 5, 2026

John R. Schroer

officer: Chief Financial Officer

ALMSSell · Aug 5, 2026

Foresite Labs, LLC

10 percent owner

ALMSBuy · Jan 12, 2026

Explore More Insider Trading Data

ALMS Insider Trading Activity

View all insider trades at Alumis Inc. Common Stock

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity